Approvals/TGA/AJOVY fremanezumab 225 mg/1.5 mL solution for injection in an autoinjector

Approved

STANDARD

AJOVY fremanezumab 225 mg/1.5 mL solution for injection in an autoinjector

Teva Pharma Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 226340e753a5df41
Product Name: AJOVY fremanezumab 225 mg/1.5 mL solution for injection in an autoinjector
Artg Id: 342612
Artg Name: AJOVY fremanezumab 225 mg/1.5 mL solution for injection in an autoinjector
Sponsor: Teva Pharma Australia Pty Ltd
Company Detail Path: /organization/teva-pharma-australia-pty-ltd
Artg Date: 2021-06-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2020-CMI-01901-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2019-PI-01962-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

226340e753a5df41

Type

Standard